Lucian C. Chen is Head of Patent Litigation and Prosecution and a Partner in Mandelbaum Barrett PC’s Intellectual Property Practice Group. With a remarkable career spanning over two decades, Mr. Chen specializes in a wide spectrum of commercial and intellectual property law, focusing on various technology sectors. His primary areas of experience encompass complex high-tech, pharmaceutical, and biotechnology patent and trademark litigation, intellectual property transactions, due diligence, and contract negotiations.
Mr. Chen has successfully represented clients in multi-billion-dollar patent and trademark litigation cases involving diverse products, such as computer software, antifungals, antibiotics, personal electronics, and cholinesterase inhibitors. His extensive involvement in all aspects of intellectual property litigation includes advising clients, initiating litigation, and conducting both bench and jury trials, such as numerous Hatch-Waxman cases.
In addition to his litigation prowess, he is well-versed in preparing pre-suit investigations, offering non-infringement opinions, negotiating licensing and settlement agreements, and conducting intellectual property due diligence. He also provides invaluable counsel to clients dealing with trademark and copyright disputes, as well as manages the preparation and prosecution of patent, trademark, design patent, and copyright applications. He is also recognized for his commitment to representing scientists and professors before institutional boards, in administrative hearings, and during litigation proceedings.
Before embarking on his legal career, he served as the Founding Editor-in-Chief of BioProcessing, a prestigious peer-reviewed journal dedicated to the industrial biotechnology industry. His journalism career includes significant roles such as Associate Managing Editor of Genetic Engineering News, a leading trade publication in the biotechnology field. Additionally, Mr. Chen served as Managing Director and Editor for a group of science websites within the VerticalNet e-commerce family. He continues to contribute to the field as a board member of the journal Biotechnology Law Report, where he also held the position of Editor-in-Chief.
Mr. Chen’s legal acumen and extensive experience make him an invaluable asset to the firm’s Intellectual Property and Brand Management Practice Group, as well as a respected figure in the field of Intellectual Property law.
Lucien has made substantial contributions to legal scholarship through various publications. Some of his notable works include:
- “Biosimilar Companies Chipping Away at Humira, but No Death Knells Yet” – Biotechnology Law Report, 36(3): 75-77 (2017).
- “After Two Years, Alice Is Still Stifling Life Sciences Patents; But the Tide May Be Shifting at the Federal Circuit” – Biotechnology Law Report, 35(5): 239-244 (2016).
- “Clarity Emerging on Personal Jurisdiction in Pharma and Biologics Litigation” – Biotechnology Law Report, 35(2): 55-59 (2016).
- “Patenting Nanotech Inventions: Strategic Early Positioning May Protect Portfolio Once Litigation Emerges” – Industrial Biotechnology; 1:3: 153 (2005).
- “Enablement in the Spotlight: Federal Circuit applied foreseeability standard for biotech patents” – National Law Journal; June 16, 2003.
- “Chemdex Closing, Shifts E-Marketplace Picture” – Genetic Engineering News; 21:1: 12 (2001).
- “Mass Spec Leads News from PittCon: Life Scientists Welcome Increased Data” – Genetic Engineering News; 20:7: 12 (2000).
- “PE and HP to Divide Operations: Both Realignments Will Allow the Companies to Focus on Core Business” – Genetic Engineering News; 19:7: 11 (1999).
- “O.J. Simpson Case Sparks a Flurry of Interest in DNA Fingerprinting Methods” – Genetic Engineering News; 14:14: 1 (1994).
- “Transgenic Mice Surge Toward Acceptance in the Marketplace” – Genetic Engineering News; 13:19: 1 (1993).
- “Modulation of epidermal growth factor receptors by gamma interferon in a breast cancer cell line” – Anticancer Research; 11: 347 352 (1991).
- “Density dependent regulation of epidermal growth factor receptor expression” – Pathobiology; 59: 329 334 (1991).
- “Enhancement of anchorage independent growth of a human adrenal carcinoma cell line by endogenously produced basic fibroblast growth factor” – International Journal of Cancer; 46: 516 521 (1990).
New York
United States Patent & Trademark Office
United States Supreme Court
United States District Court for the Southern District of New York
United States District Court for the Eastern District of New York
United States District Court for the Eastern District of Texas
B.A., Johns Hopkins University
M.P.H., Columbia University
J.D., St. John’s University School of Law
Navigating IP: Trademark Litigation 101 Understanding Court Cases vs. Office Proceedings
November 18, 2024
At Mandelbaum Barrett PC, our Intellectual Property (IP) team understands that securing and protecting your brand is key to building a successful business. Obtaining a federal trademark is often a critical step, allowing businesses to enforce their rights and protect their unique identities in federal court. However, trademark protection doesn’t end there. There are alternative […]Navigating IP: Trademark Tips for Business Owners Lessons from Nike
October 17, 2024
At Mandelbaum Barrett PC, our Intellectual Property (IP) team is committed to helping businesses protect their most valuable asset—their brand. Whether you’re a startup or an established company, trademarking your business name, slogan, or logo is an essential step to ensure that your brand identity is secure. Our attorneys guide you through the trademark process, […]Navigating IP: Protect Your App Trademark Intent vs Active Use
October 9, 2024
At Mandelbaum Barrett PC, our Intellectual Property (IP) team offers comprehensive trademark services to protect your brand, including mobile and web applications. Whether you’re still in the development stage or your app is already available for download, we provide the legal support you need to secure your trademark. Intent to Use Applications If your app […]Navigating IP: Patents vs. Trademarks Timelines & Challenges
September 26, 2024
At Mandelbaum Barrett PC, our Intellectual Property (IP) department offers comprehensive, end-to-end services for both patents and trademarks. Our experienced team provides what we call “full boat intellectual property” support, meaning we handle every stage of the process -- from prosecuting to litigating patents and trademarks.The Crucial Benefits of Early Trademark Filing
July 11, 2024
Todd M. Nosher and Lucian C. Chen from Mandelbaum Barrett PC emphasize the critical role of early trademark filing in safeguarding businesses. By securing trademarks promptly, companies can preempt legal issues and establish vital protections for their brands, ensuring long-term success and avoiding costly disputes. Watch their insights here: https://youtu.be/tLA5VIOn-acSpicy Saga of Chili Crunch Trademark Rights
April 29, 2024
In a heated twist on intellectual property debates, the Chili Crunch controversy has simmered into the spotlight, showcasing the spicy interplay between legal battles and brand image in the culinary world. In a revealing discussion, Lucian Chen and Todd M. Nosher peel back the layers of this recent trademark tussle involving Momofuku, serving up a rich narrative that highlights the evolving challenges in the food industry’s trademark landscape.